Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Journal of Cardiac Failure

Volumn 15, Issue 10, 2009, Pages 835-842

  Carson, Peter ^a   Tam, S William ^b   Ghali, Jalal K ^c   Archambault, W Tad ^d   Taylor, Anne ^e   Cohn, Jay N ^f   Braman, Virginia M ^b   Worcel, Manuel ^b   Anand, Inder S ^f,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NitroMed Inc   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Virtu Stat Ltd   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Heart failure; morbidity; nitric oxide; quality of life; race

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; PLACEBO;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART FAILURE; HEART RATE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AFRICAN AMERICANS; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70450225256     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.05.016     Document Type: Article

References (35)

1. Cohn J.N. The management of chronic heart failure. N Engl J Med 335 (1996) 490-498
2. Carson P., Tognoni G., and Cohn J.N. Effect of Valsartan on hospitalization: results from ValHeFT. J Card Fail 9 (2003) 164-171
3. Rector T.S., Francis G.S., and Cohn J.N. Patients' self-assessment of their congestive heart failure. Part 1: patient perceived dysfunction and its poor correlation with maximal exercise tests. Heart Failure (1987) 192-196
4. Rector T.S., Kubo S.H., and Cohn J.N. Patients' self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure (1987) 198-209
5. Rector T.S., Johnson G., Dunkman W.B., Daniels G., Farrell L., Henrick A., et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87 (1993) VI71-VI77
6. Gorkin L., Norvell N.K., Rosen R.C., Charles E., Schumaker S.A., Melntyre K.M., et al., for the SOLVD Investigators. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol 71 (1993) 1069-1073
7. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with heart failure questionnaire as a measure of therapeutic response to Enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
8. Rector T.S., Tschumperlin L.K., Kubo S.H., Bank A.J., Francis G.S., McDonald K.M., et al. Use of the Living with Heart Failure questionnaire to ascertain patients' perspective on improvement in quality of life versus risk of drug-induced death. J Cardiac Failure 1 (1995) 201-206
9. Konstam V., Salem D., Pouleur H., Kostis J., Gorkin L., Shumaker S., et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. Am J Cardiol 78 (1996) 890-895
10. Hulsmann M., Berger R., Sturm B., et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J 23 (2002) 886-891
11. Cowley A.J., Wiens B.L., Segal R., Rich M.W., Santanello N.C., et al. Randomized comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy. Qual Life Res 9 (2000) 377-384
12. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). JAMA 283 (2000) 1295-1302
13. Alla F., Briancon S., Guillemin F., et al. Self-rated quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail 4 (2002) 337-343
14. Lader E., Egan D., Hunsberger S., et al. The effect of digoxin on the quality of life in patients with heart failure. J Card Fail 9 (2003) 4-12
15. Rodriguez-Artalejo F., Guallar-Castillon P., Pascual C.R., et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med 165 (2005) 1274-1279
16. Majani G., Giardini A., Opasich C., et al. Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial. J Card Fail 11 (2005) 253-259
17. Tate C.W., Robertson A.D., Zolty R., et al. Quality of life and prognosis in heart failure: results of the beta-blocker evaluation of survival trial (BEST). J Card Fail 13 (2007) 732-737
18. Lewis E.F., Lamas G.A., Meara E.O., et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail 9 (2007) 83-91
19. Ghali J.K., Anand I.S., Abraham W.T., et al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 117 (2008) 526-535
20. Kubo S.H., Schulman S., Starling R.C., Jessup M., Wentworth D., and Burkhoff D. Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail 10 (2004) 228-235
21. Taylor A.L., Ziesche S., Yancy C., Carson P., D'Agostino Jr. R., Ferdinand K., et al. The African-American Heart Failure Trial Investigators: combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
22. Franciosa J.A., Taylor A.L., Cohn J.N., et al. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. J Card Fail 8 (2002) 128-135
23. Taylor A.L., Ziesche S., Yancy C.W., Carson P., Ferdinand K., Taylor M., et al. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation 115 (2007) 1747-1753
24. Conard M.W., Haddock K., Poston W.S.C., et al. Impact of obesity on the health status of heart failure patients. J Card Fail 12 (2006) 700-706
25. Masoudi F.A., Rumsfeld J.S., Havraned E.P., et al. Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail 10 (2004) 368-373
26. Rector T.S., Anand I.S., and Cohn J.N. Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. J Card Fail 12 (2006) 87-92
27. Chin M.H., and Goldman L. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care 36 (1998) 1033-1046
28. Rumsfeld J.S., Havranek E., Masoudi F.A., et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 42 (2003) 1811-1817
29. Havranek E.P., Spertus J.A., Masoudi F.A., et al. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 44 (2004) 2333-2338
30. Luther S.A., McCullough P.A., Havranek E.P., et al. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail 11 (2005) 414-421
31. Best VA Coordinating Center; personal communication, 2007.
32. Heidenreich P.A., Spertus J.A., Jones P.G., et al. Health status identifies heart failure outpatients at risk for hospitalizations or death. J Am Coll Cardiol 47 (2006) 752-756
33. Soto G.E., Jones P., Weintraub W.S., et al. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 110 (2004) 546-551
34. Kosiborod M., Soto G.E., Jones P.G., et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation 115 (2007) 1975-1981
35. Dorbe D., van Jaarsveld C.H., deJongste M.J., et al. The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Safety 16 (2007) 152-159